Heidi Zhang
Juno Therapeutics, A Bristol-Myers Squibb Company
Dr. Heidi Zhang is the Vice President of Product and Analytical Development in Cell Therapy Development Organization at BMS. Previously, she held positions of various responsibilities at Genentech, Novartis and Amgen. Heidi aspires to improve human health through science and leadership. Her proudest accomplishments include multiple drug approvals, technical innovation, and talent development. She is active in various industry/academia/regulatory alliance network and consortium.